Concepedia
Statistics
Publications
17
Citations
687
H-Index
14
Active since
1981
Affiliations
Dow Chemical (United States)(Current)
Newport Hospital
University of Michigan
Stephen W. Frantz is an author at Dow Chemical (United States) specializing in pharmacy, pharmacokinetics, and bioavailability.
Publications per year
1981–2001
Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels
Valentin K. Gribkoff, John E. Starrett, Steven I. Dworetzky et al. · Nature Medicine · 2001 · 311 citations
Life Sciences, Neurology, Neuroscience +16
Nuclear Energy: Principles, Practices, and Prospects
David Bodansky, Stephen W. Frantz · American Journal of Physics · 1997 · 42 citations
Engineering, Nuclear Engineering, Public Policy +17
Substituent effects on the mutagenicity of phenyl glycidyl ethers in Salmonella typhimurium
Steven H. Neau, B.H. Hooberman, Stephen W. Frantz et al. · Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis · 1982 · 41 citations · Full text
Pharmacy, Microbiology, Toxicology +6
Bacterial mutagenicity and toxicity of cycloaliphatic epoxides
Stephen W. Frantz, Joseph E. Sinsheimer · Mutation Research/Genetic Toxicology · 1981 · 35 citations · Full text
Pharmacy, Microbiology, Toxicology +11
Pharmacokinetics of ethylene glycol II. Tissue distribution, dose-dependent elimination, and identification of urinary metabolites following single intravenous, peroral or percutaneous doses in female Sprague-Dawley rats and CD-1® mice*
Stephen W. Frantz, Joyce L. Beskitt, C M Grosse et al. · Xenobiotica · 1996 · 35 citations
Pharmacy, Pharmacokinetics, Pharmacology +14
1–5 of 17